Literature DB >> 11550808

Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis.

Y Kaburagi1, Y Shimada, T Nagaoka, M Hasegawa, K Takehara, S Sato.   

Abstract

CC-chemokines are potent molecules that direct the migration of leukocytes to inflammatory foci. To determine their role in inflammation associated with atopic dermatitis (AD), we determined serum levels and spontaneous production of CC-chemokines by peripheral blood mononuclear cells (PBMC) in AD patients using an ELISA. Serum levels of RANTES, MCP-1, MIP-1beta, and eotaxin were increased in AD patients (n = 52) compared with normal controls (n = 22). Serum levels of RANTES, MCP-1, and MIP-1beta were increased in AD patients with severe disease (n = 19) compared with normal controls (n = 22). Spontaneous production of RANTES, MCP-1, MIP-1alpha and MIP-1beta by PBMC was augmented in AD patients (n = 39) and in patients with severe AD (n = 14) compared with normal controls (n = 20). Serum RANTES levels correlated with total serum IgE levels, eosinophil numbers, and serum lactate dehydrogenase levels. Our results suggest that augmented production of CC-chemokines correlates with inflammation associated with AD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11550808     DOI: 10.1007/s004030100230

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  30 in total

1.  Oral administration of Vaccinium uliginosum L. extract alleviates DNCB-induced atopic dermatitis in NC/Nga mice.

Authors:  Kang-Hyun Kim; Se-Young Choung
Journal:  J Med Food       Date:  2014-12       Impact factor: 2.786

Review 2.  Protecting the boundary: the sentinel role of host defense peptides in the skin.

Authors:  Jamie J Bernard; Richard L Gallo
Journal:  Cell Mol Life Sci       Date:  2011-05-15       Impact factor: 9.261

3.  Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells.

Authors:  S Kagami; H Saeki; M Komine; T Kakinuma; Y Tsunemi; K Nakamura; K Sasaki; A Asahina; K Tamaki
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 4.  An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis.

Authors:  Zahra Ahmadi; Gholamhossein Hassanshahi; Hossein Khorramdelazad; Nahid Zainodini; Leila Koochakzadeh
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

5.  Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart.

Authors:  Nicola L Diny; Xuezhou Hou; Jobert G Barin; Guobao Chen; Monica V Talor; Julie Schaub; Stuart D Russell; Karin Klingel; Noel R Rose; Daniela Čiháková
Journal:  Eur J Immunol       Date:  2016-10-25       Impact factor: 5.532

6.  Tumor necrosis factor-α, monocyte chemoattractant protein-1 and intercellular adhesion molecule-1 increase during the development of a 2,4-dinitrofluorobenzene-induced immediate-type dermatitis in rats.

Authors:  Guangchen Sun; Yaqin Wang; Bo Yin; Lingjin Zhu; Yingqin Liu
Journal:  Inflamm Res       Date:  2013-03-26       Impact factor: 4.575

Review 7.  Antimicrobial peptides, skin infections, and atopic dermatitis.

Authors:  Tissa R Hata; Richard L Gallo
Journal:  Semin Cutan Med Surg       Date:  2008-06

8.  Dexamethasone and FK506 inhibit expression of distinct subsets of chemokines in human mast cells.

Authors:  Atsushi Kato; Regina T Chustz; Takahisa Ogasawara; Marianna Kulka; Hirohisa Saito; Robert P Schleimer; Kenji Matsumoto
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

Review 9.  Eosinophil function in allergic inflammation: from bone marrow to tissue response.

Authors:  Darryl Adamko; Paige Lacy; Redwan Moqbel
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

10.  An eosinophil immune response characterizes the inflammatory skin disease observed in Tie-2 transgenic mice.

Authors:  Daniel Voskas; Yael Babichev; Ling S Ling; Jennifer Alami; Yuval Shaked; Robert S Kerbel; Brian Ciruna; Daniel J Dumont
Journal:  J Leukoc Biol       Date:  2008-05-01       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.